Entrada Therapeutics Inc (TRDA) — Free Cash Flow Generation Index
Entrada Therapeutics Inc (TRDA) has a Free Cash Flow Generation Index of 0.97x as of June 2024. Free cash flow of $38.79 Million represents 1% of operating cash flow ($39.83 Million). See TRDA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Entrada Therapeutics Inc Free Cash Flow Generation Index (2023–2023)
Historical FCF Generation Index trend for Entrada Therapeutics Inc across 1 annual periods. Explore TRDA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Entrada Therapeutics Inc (2023–2023)
Year-by-year Free Cash Flow Generation Index for Entrada Therapeutics Inc. For the full company profile including market capitalisation, see how much is Entrada Therapeutics Inc worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.96x | $134.19 Million | $139.80 Million | $5.61 Million | — |